For most pregnant people with opioid use disorder, staying on Suboxone is safer than stopping it. Buprenorphine, the active medication in Suboxone, is first-line treatment in pregnancy and one of the medications we use for treatment during pregnancy. The comparison that matters is not medication versus nothing. It is medication versus untreated opioid use.
Buprenorphine-based medication, including Suboxone, is recommended during pregnancy because untreated opioid use disorder carries more risk than the medication does. Your baby may need monitoring for withdrawal after birth, breastfeeding is usually encouraged, and stopping medication is the option health agencies advise against most strongly.
Suboxone combines buprenorphine, a partial opioid agonist, with naloxone, an opioid blocker included to discourage misuse. Buprenorphine occupies opioid receptors firmly enough to hold off withdrawal and cravings without producing the highs and crashes of illicit opioid use.
Steadiness is the point.
A pregnancy exposed to one stable daily dose is not in the same position as a pregnancy exposed to repeated cycles of intoxication and withdrawal, which is what ongoing fentanyl or heroin use looks like physiologically. That difference is why clinicians treat medication as protective here rather than as a risk to be minimized.
Our Suboxone therapy program is built around holding that dose steady, in an outpatient setting, for as long as it is helping.
Guidance here is unusually direct.
The Centers for Disease Control and Prevention recommends medication for opioid use disorder during pregnancy rather than supervised withdrawal, and names methadone and buprenorphine as the first-line options. Stopping quickly is the part that carries documented danger. For how buprenorphine works outside of pregnancy, our guide to Suboxone for opioid dependence covers the basics.
The CDC lists three possible consequences of rapidly stopping opioids during pregnancy:
An advisory from SAMHSA reaches the same conclusion on two grounds: the harm supervised withdrawal can cause both the pregnant person and the fetus, and the high likelihood of returning to opioid use afterward.
This one comes up constantly, and the answer has shifted.
The buprenorphine monoproduct, sold as Subutex, was historically preferred during pregnancy for one specific reason: it avoids exposing a fetus to naloxone.
That preference has softened. The joint recommendation from the American Society of Addiction Medicine and the American College of Obstetricians and Gynecologists points to recent studies of the combination product that found no adverse effects, with outcomes comparable to buprenorphine alone.
Either formulation can be reasonable. Someone already doing well on Suboxone is not usually asked to switch, and the choice belongs to you and your prescriber rather than to a rule of thumb.
Both are considered first-line, and neither is universally better. The right choice usually comes down to stability, structure, and access rather than to pregnancy itself.
| Factor | Buprenorphine (Suboxone or Subutex) | Methadone |
| Where You Get It | Prescribed in an office or clinic setting, and by telehealth in some situations | Dispensed through a licensed opioid treatment program, often daily at first |
| Dosing Later in Pregnancy | May need adjustment, particularly in the third trimester | May need adjustment; split dosing is sometimes used in the third trimester |
| Newborn Withdrawal | Possible; delivery hospitals monitor and treat it | Possible; delivery hospitals monitor and treat it |
| Often Suited For | People who do well on a stable dose with less frequent visits | People who have not stabilized on buprenorphine, or who benefit from daily structure |
Someone already stable on one medication rarely has reason to switch mid-pregnancy. If you are choosing for the first time, a closer look at how Suboxone and methadone compare covers the trade-offs in more depth.
Pregnancy changes how your body processes medication. Blood volume rises, metabolism speeds up, and a dose that held you steady in the first trimester may not hold you steady in the third.
ASAM and ACOG note that these changes may call for dose adjustments, particularly in the third trimester, while making clear that not everyone needs an increase.
A few changes are worth reporting to your prescriber rather than waiting out:
Babies exposed to buprenorphine before birth may develop neonatal opioid withdrawal syndrome, sometimes called NAS. Symptoms typically appear in the first days after delivery and can include:
Hospitals plan for this.
The CDC treats NAS as an expected condition following medication exposure and is explicit that concern about it should not stop a provider from prescribing. SAMHSA reports that incidence rose from 1.2 to 8.8 per 1,000 hospital births between 2000 and 2016, which is part of why delivery teams now have well-established screening and treatment protocols.
Your part is straightforward. Tell your obstetric provider and your delivery hospital which medication you take and at what dose, well before your due date, so the newborn team knows what to watch for.
Breastfeeding is generally encouraged rather than discouraged. The National Institutes of Health LactMed database describes buprenorphine as acceptable for nursing mothers, including long-acting forms, because milk levels are low and infants absorb very little of it.
There is a secondary benefit. SAMHSA notes that breastfeeding while taking medication for opioid use disorder can reduce the severity of newborn withdrawal, shorten hospital stays, and lower the chance an infant needs medication to treat it.
LactMed does advise seeking care promptly if the baby shows any of the following:
The postpartum months carry more risk than pregnancy does, which surprises many people.
ASAM and ACOG report that women return to opioid use far more often after delivery than during pregnancy, and recommend continuing medication postpartum alongside overdose training and a naloxone prescription. Sleep loss, a new baby, and the end of intensive prenatal appointments all land at once.
Keeping medication for addiction treatment in place through that stretch, rather than tapering during it, is what the evidence supports.
You do not need to have it figured out before you call.
Porch Light Health provides outpatient medication for addiction treatment, counseling, and psychiatric care at clinics, mobile medical sites, and by telehealth across Colorado and New Mexico. We accept Medicaid and Medicare, work with major commercial plans, and offer a sliding-fee program for people who qualify.
Coverage varies by plan and by state, so checking your benefits before a first visit is the fastest way to avoid surprises.
Call 866-839-8868 or get in touch with our team to ask about starting or continuing treatment during pregnancy.
Will my baby be born addicted if I take Suboxone?
No. Addiction is a behavioral condition, and a newborn cannot have it. A baby can be born physically dependent and go through withdrawal, which is temporary and treatable.
Should I switch from Suboxone to Subutex now that I’m pregnant?
Not automatically. The monoproduct was once preferred to avoid fetal naloxone exposure, but more recent studies found comparable outcomes between the two. Raise it with your prescriber rather than changing anything on your own.
Is it too late to start treatment if I’m already in my third trimester?
No. Starting later in pregnancy still reduces the risks tied to ongoing opioid use, and it gives your delivery team time to prepare for newborn monitoring.
Can I breastfeed while taking Suboxone?
Usually yes. LactMed describes buprenorphine as acceptable during breastfeeding, and SAMHSA notes it may reduce how severe newborn withdrawal becomes. Your pediatric team will watch the baby for sleepiness, feeding problems, or poor weight gain.
Will Suboxone affect pain control during labor and delivery?
It can change the plan, which is why your delivery team needs to know in advance. Tell your obstetric provider and the hospital which medication and dose you take so they can arrange pain management ahead of time.
What happens if I stop taking Suboxone while pregnant?
Stopping is the course health agencies advise against. The CDC ties rapidly stopping opioids in pregnancy to preterm labor, fetal distress, and miscarriage, and both SAMHSA and ASAM point to a high likelihood of returning to opioid use afterward.
Does Medicaid cover Suboxone during pregnancy?
Medicaid generally covers medication for opioid use disorder, though rules and authorization steps differ by state and plan. Our guide on whether Medicaid covers Suboxone walks through what to ask, and our team can help you check your specific benefits.
Can I stay in treatment if I live far from a clinic?
Often yes. We deliver care through in-person clinics, mobile medical sites, and telehealth visits, which is built for people in rural and frontier communities where the nearest clinic is a long drive.
Pregnancy is one of the most common reasons people reach out for the first time, and it is a reasonable moment to do it. Treatment is confidential, outpatient, and built around keeping you stable rather than putting you through withdrawal.
Call Porch Light Health at 866-839-8868 or contact us online to talk with someone about medication, counseling, and what care would look like for you.
